300391 Stock Overview
Engages in the production and distribution of pharmaceuticals and photovoltaic equipment in China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
My Notes
Capture your thoughts, links and company narrative
Changjiang Pharmaceutical Group Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥4.93 |
| 52 Week High | CN¥8.14 |
| 52 Week Low | CN¥2.24 |
| Beta | 0.013 |
| 1 Month Change | 2.28% |
| 3 Month Change | -20.61% |
| 1 Year Change | 36.94% |
| 3 Year Change | -66.76% |
| 5 Year Change | -40.67% |
| Change since IPO | 30.47% |
Recent News & Updates
Changjiang Pharmaceutical Group Co., Ltd.'s (SZSE:300391) 26% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio
Dec 31
Changjiang Pharmaceutical Group Co., Ltd.'s (SZSE:300391) Shares Climb 53% But Its Business Is Yet to Catch Up
Nov 14Revenues Not Telling The Story For Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) After Shares Rise 45%
Sep 30Recent updates
Changjiang Pharmaceutical Group Co., Ltd.'s (SZSE:300391) 26% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio
Dec 31Changjiang Pharmaceutical Group Co., Ltd.'s (SZSE:300391) Shares Climb 53% But Its Business Is Yet to Catch Up
Nov 14Revenues Not Telling The Story For Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) After Shares Rise 45%
Sep 30Investors Don't See Light At End Of Changjiang Pharmaceutical Group Co., Ltd.'s (SZSE:300391) Tunnel And Push Stock Down 31%
Aug 11Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) Looks Inexpensive After Falling 29% But Perhaps Not Attractive Enough
Jun 17Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) Looks Inexpensive After Falling 38% But Perhaps Not Attractive Enough
Apr 17Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) Not Doing Enough For Some Investors As Its Shares Slump 25%
Feb 27Shareholder Returns
| 300391 | CN Auto Components | CN Market | |
|---|---|---|---|
| 7D | 11.3% | -0.7% | 1.5% |
| 1Y | 36.9% | 42.6% | 20.7% |
Return vs Industry: 300391 underperformed the CN Auto Components industry which returned 42.6% over the past year.
Return vs Market: 300391 exceeded the CN Market which returned 20.7% over the past year.
Price Volatility
| 300391 volatility | |
|---|---|
| 300391 Average Weekly Movement | 10.4% |
| Auto Components Industry Average Movement | 6.6% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in CN Market | 10.5% |
| 10% least volatile stocks in CN Market | 3.7% |
Stable Share Price: 300391's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 300391's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1963 | 596 | n/a | www.chinakangyue.com |
Changjiang Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the production and distribution of pharmaceuticals and photovoltaic equipment in China and internationally. It offers photovoltaic equipment, such as laminating machines and stitch welding machines; tablets and hollow capsules; and Chinese herbal beverages, as well as engages in pharmaceutical distribution business. The company was formerly known as Kangyue Technology Co., Ltd.
Changjiang Pharmaceutical Group Co., Ltd. Fundamentals Summary
| 300391 fundamental statistics | |
|---|---|
| Market cap | CN¥1.73b |
| Earnings (TTM) | -CN¥670.77m |
| Revenue (TTM) | CN¥276.70m |
6.2x
P/S Ratio-2.6x
P/E RatioIs 300391 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300391 income statement (TTM) | |
|---|---|
| Revenue | CN¥276.70m |
| Cost of Revenue | CN¥261.57m |
| Gross Profit | CN¥15.13m |
| Other Expenses | CN¥685.90m |
| Earnings | -CN¥670.77m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Apr 21, 2025
| Earnings per share (EPS) | -1.91 |
| Gross Margin | 5.47% |
| Net Profit Margin | -242.42% |
| Debt/Equity Ratio | 106.9% |
How did 300391 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/16 13:09 |
| End of Day Share Price | 2025/02/14 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Changjiang Pharmaceutical Group Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Xue Deng | Tianfeng Securities Brokerage Co., Ltd |